Edap Tms (NASDAQ:EDAP – Get Rating) had its price objective upped by stock analysts at Piper Sandler from $11.00 to $12.00 in a research report issued to clients and investors on Thursday, The Fly reports. Piper Sandler’s price target would suggest a potential upside of 20.60% from the stock’s previous close.
A number of other equities research analysts also recently issued reports on the stock. StockNews.com initiated coverage on shares of Edap Tms in a research report on Wednesday, October 12th. They set a “hold” rating for the company. Jefferies Financial Group initiated coverage on shares of Edap Tms in a research note on Tuesday, November 1st. They set a “buy” rating and a $11.00 target price on the stock.
Edap Tms Trading Down 3.8 %
Shares of EDAP stock opened at $9.95 on Thursday. Edap Tms has a 1 year low of $5.13 and a 1 year high of $10.60. The firm has a fifty day moving average price of $8.86 and a 200-day moving average price of $7.72. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.58 and a quick ratio of 3.18. The company has a market cap of $359.64 million, a price-to-earnings ratio of 90.46 and a beta of 1.22.
Institutional Trading of Edap Tms
Several hedge funds have recently bought and sold shares of EDAP. Camarda Financial Advisors LLC purchased a new stake in Edap Tms in the 1st quarter worth $209,000. JPMorgan Chase & Co. purchased a new stake in Edap Tms in the 1st quarter worth $60,000. HighTower Advisors LLC purchased a new stake in Edap Tms in the 1st quarter worth $185,000. Rock Springs Capital Management LP lifted its stake in Edap Tms by 7.8% in the 1st quarter. Rock Springs Capital Management LP now owns 820,000 shares of the medical equipment provider’s stock worth $5,945,000 after purchasing an additional 59,100 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its holdings in shares of Edap Tms by 8.3% in the 2nd quarter. Commonwealth Equity Services LLC now owns 52,225 shares of the medical equipment provider’s stock worth $355,000 after buying an additional 4,000 shares during the last quarter. Hedge funds and other institutional investors own 28.53% of the company’s stock.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).
- Get a free copy of the StockNews.com research report on Edap Tms (EDAP)
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
- How High Can the Fed Go? How to Trade it
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.